Tang, W. H. W., Francis, G. S., Morrow, D. A., Newby, L. K., Cannon, C. P., Jesse, R. L., … NACB Committee, . (2008). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin Biochem, 41(4–5), 210–221. https://doi.org/10.1016/j.clinbiochem.2007.07.002

Tang, WH Wilson, Gary S. Francis, David A. Morrow, L Kristin Newby, Christopher P. Cannon, Robert L. Jesse, Alan B. Storrow, Robert H. Christenson, and Robert H. NACB Committee. “National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.” Clin Biochem 41, no. 4–5 (March 2008): 210–21. https://doi.org/10.1016/j.clinbiochem.2007.07.002.

Tang WHW, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin Biochem. 2008 Mar;41(4–5):210–21.

Tang, WH Wilson, et al. “National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.” Clin Biochem, vol. 41, no. 4–5, Mar. 2008, pp. 210–21. Pubmed, doi:10.1016/j.clinbiochem.2007.07.002.

Tang WHW, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, Storrow AB, Christenson RH, NACB Committee. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin Biochem. 2008 Mar;41(4–5):210–221.